Search results
FDA Declines To Approve Merck-Daiichi Sankyo Partnered Lung Cancer Drug
Benzinga via Yahoo Singapore Finance· 3 days agoOn Wednesday, the FDA issued a Complete Response Letter (CRL) for the Biologics License Application...
Regenxbio (RGNX) Soars 6.4%: Is Further Upside Left in the Stock?
Zacks via Yahoo Singapore Finance· 5 days agoRegenxbio (RGNX) saw its shares surge in the last session with trading volume being higher than...
Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
Zacks via Yahoo Singapore Finance· 2 days agoMerck’s and AbbVie’s Pipeline Candidates: The FDA issued a complete response letter (“CRL”) to Merck...
Why Did Analysts Maintain a Bullish Stance on REGENXBIO Inc. (RGNX) Despite Decline In Its Revenue...
Insider Monkey via Yahoo Singapore Finance· 3 days agoWe recently compiled a list of the Top 10 Small-Cap Stocks with Highest Upside Potential. In this...